Skip to main content
Premium Trial:

Request an Annual Quote

The Journey Is Half the Fun

At Genomes Unzipped, the Foundation for Genomics and Population Health's Caroline Wright says some regulation of the direct-to-consumer genetic testing field would be good — "to iron out the irregularities and squeeze out the fraudsters." However, she cautions that too much regulation could curtail exploration of the human genome. "Learning about one's genome, engaging one's own data, is undoubtedly a voyage of discovery. It is an exploration of science, of genetics, and finally of one's self," Wright says. She also wonders whether consumer genomics might be a way to engage the public to learn more about science. "By getting people personally involved in data analysis, and grappling with complex scientific ideas and medical realities, personal genomics services offer us a glimpse into the elite world of modern science," she writes.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.